Protein detail

ANO1

Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2)

Protein symbol
ANO1
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
10
Protein classification
Disease related genesFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2)
Protein Class
Disease related genesFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters
Protein Function
  • Disease related genes
  • Transporters:Transporter channels and pores
  • FDA approved drug targets:Small molecule drugs
  • Predicted intracellular proteins
Transmembrane
334..354; Helical; 407..427; Helical; 520..540; Helical; 569..589; Helical; 608..628; Helical; 658..678; Helical; 726..746; Helical; 747..767; Helical; 785..805; Helical; 893..913; Helical
Transmembrane Count
10
Entrez Gene Symbol
Gene Synonym
DOG1FLJ10261ORAOV2TAOS2TMEM16A
Gene Description
Anoctamin 1
Chromosome
11
Position
69985907-70189530
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
Tissue SpecifictestisCell SpecificDistal convoluted tubule cellsBlood Cell SpecificbasophilBlood Lineage Specificgranulocytes
Function & Pathway
Protein Function
  • Disease related genes
  • Transporters:Transporter channels and pores
  • FDA approved drug targets:Small molecule drugs
  • Predicted intracellular proteins
Canonical Pathways
  • M83 Pid cdc42 reg pathway
  • M241 Pid rac1 reg pathway
Mediation Categories
Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

18 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembranetransmembraneOmniPathNoNoNoNoNo
plasma_membraneplasma_membraneUniProt_locationNoNoNoNoNo
apical_cell_membraneplasma_membraneUniProt_locationNoNoNoNoNo
plasma_membraneplasma_membraneOmniPathNoNoNoNoNo
cell_surfacecell_surfaceSurfaceomeNoNoNoNoNo
cell_surfacecell_surfaceOmniPathNoNoNoNoNo
receptorreceptorscConnectNoYesNoNoNo
transmembranetransmembrane_predictedPhobiusNoNoNoNoNo
Page 2 of 2Previous

Regulatory Interaction Network

0 records.

Protein Complex Composition

1 record.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
ANO10Q9NW152PDBPDB:6r7zPDB:6r7yPDB:5oc9PDB:6r65PDB:6r7x

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometryMass spectrometry [LTQ-FT Ultra]130915084
Sequence, Structure & Domains

Sequences

Length
986
Mass
114,078
Sequence
MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL
Alternative Products
Event=Alternative splicing; Named isoforms=5; Name=1; Synonyms=TMEM16A(ac); IsoId=Q5XXA6-1; Sequence=Displayed; Name=2; IsoId=Q5XXA6-2; Sequence=VSP_025665, VSP_025668, VSP_025669; Name=3; IsoId=Q5XXA6-3; Sequence=VSP_025666, VSP_025667, VSP_025668, VSP_025669, VSP_025670, VSP_025671; Name=4; Synonyms=TMEM16A(ac-delta-e3); IsoId=Q5XXA6-4; Sequence=VSP_061540, VSP_025669; Name=5; Synonyms=Ano1(+0); IsoId=Q5XXA6-5; Sequence=VSP_061539, VSP_061541
Alternative Sequence
1..116; Missing (in isoform 2); 1..28; Missing (in isoform 3); 1; M -> MQEGDIGLEGLPPREVPTVEAAGAVDGEGAPPGGPSAQAATM (in isoform 5); 29..36; GYLPSEGT -> MLTRPSQV (in isoform 3); 148..180; Missing (in isoform 4); 267; G -> GQGEGRKKDSALLSKRRKCGKYG (in isoform 5); 448..451; Missing (in isoform 2 and isoform 3); 476..501; Missing (in isoform 2, isoform 3 and isoform 4); 651..700; CAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSP -> VTEILFISGSPFCLAYDLSTPCTWEKQLQHICSAKSSRFLSFLLETFLFP (in isoform 3); 701..986; Missing (in isoform 3)

3D Structural Models

Domain & Motif Annotations

Compositional Bias
951..960; Basic and acidic residues
Domain (CC)
The region spanning the fifth and sixth transmembrane domains probably forms the pore-forming region.
Region
79..121; Disordered; 951..986; Disordered
Protein Families
Anoctamin family
Sequence Similarities
Belongs to the anoctamin family.
Clinical Relevance
Disease Involvement
Disease variantFDA approved drug targets
Drug Targets
FDA approved drug targets